1. Home
  2. CGTX vs SPPL Comparison

CGTX vs SPPL Comparison

Compare CGTX & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • SPPL
  • Stock Information
  • Founded
  • CGTX 2007
  • SPPL 2016
  • Country
  • CGTX United States
  • SPPL Singapore
  • Employees
  • CGTX N/A
  • SPPL N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • SPPL
  • Sector
  • CGTX Health Care
  • SPPL
  • Exchange
  • CGTX Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • CGTX 16.1M
  • SPPL 14.8M
  • IPO Year
  • CGTX 2021
  • SPPL 2023
  • Fundamental
  • Price
  • CGTX $0.63
  • SPPL $0.80
  • Analyst Decision
  • CGTX Strong Buy
  • SPPL
  • Analyst Count
  • CGTX 6
  • SPPL 0
  • Target Price
  • CGTX $8.30
  • SPPL N/A
  • AVG Volume (30 Days)
  • CGTX 20.0M
  • SPPL 217.8K
  • Earning Date
  • CGTX 11-13-2024
  • SPPL 12-31-2024
  • Dividend Yield
  • CGTX N/A
  • SPPL N/A
  • EPS Growth
  • CGTX N/A
  • SPPL N/A
  • EPS
  • CGTX N/A
  • SPPL N/A
  • Revenue
  • CGTX N/A
  • SPPL $3,550,862.00
  • Revenue This Year
  • CGTX N/A
  • SPPL N/A
  • Revenue Next Year
  • CGTX N/A
  • SPPL N/A
  • P/E Ratio
  • CGTX N/A
  • SPPL N/A
  • Revenue Growth
  • CGTX N/A
  • SPPL N/A
  • 52 Week Low
  • CGTX $0.34
  • SPPL $0.25
  • 52 Week High
  • CGTX $2.95
  • SPPL $6.72
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 69.18
  • SPPL 42.72
  • Support Level
  • CGTX $0.43
  • SPPL $0.81
  • Resistance Level
  • CGTX $1.29
  • SPPL $0.94
  • Average True Range (ATR)
  • CGTX 0.10
  • SPPL 0.07
  • MACD
  • CGTX 0.03
  • SPPL -0.04
  • Stochastic Oscillator
  • CGTX 27.88
  • SPPL 12.15

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: